Meag Munich Ergo’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.63M | Sell |
49,967
-2,662
| -5% | -$409K | 0.22% | 78 |
|
|
2025
Q1 | $8.73M | Buy |
52,629
+26,203
| +99% | +$4.1M | 0.26% | 74 |
|
|
2024
Q4 | $3.79M | Hold |
26,426
| – | – | 0.12% | 88 |
|
|
2024
Q3 | $4.28M | Buy |
26,426
+22,321
| +544% | +$3.56M | 0.13% | 92 |
|
|
2024
Q2 | $600K | Buy |
4,105
+1,132
| +38% | +$168K | 0.02% | 134 |
|
|
2024
Q1 | $470K | Sell |
2,973
-10,825
| -78% | -$1.72M | 0.02% | 141 |
|
|
2023
Q4 | $2.16M | Sell |
13,798
-329
| -2% | -$50.4K | 0.08% | 111 |
|
|
2023
Q3 | $2.2M | Sell |
14,127
-5,319
| -27% | -$878K | 0.1% | 105 |
|
|
2023
Q2 | $3.22M | Sell |
19,446
-4,715
| -20% | -$761K | 0.14% | 94 |
|
|
2023
Q1 | $3.74M | Sell |
24,161
-31,643
| -57% | -$5.11M | 0.18% | 89 |
|
|
2022
Q4 | $9.86M | Buy |
55,804
+1,724
| +3% | +$298K | 0.53% | 43 |
|
|
2022
Q3 | $8.84M | Buy |
54,080
+1,937
| +4% | +$328K | 0.54% | 43 |
|
|
2022
Q2 | $9.26M | Hold |
52,143
| – | – | 0.55% | 42 |
|
|
2022
Q1 | $9.36M | Buy |
52,143
+4,562
| +10% | +$776K | 0.68% | 36 |
|
|
2021
Q4 | $8.23M | Sell |
47,581
-72,207
| -60% | -$11.8M | 0.58% | 42 |
|
|
2021
Q3 | $19.3M | Buy |
119,788
+36,792
| +44% | +$6.28M | 3.36% | 3 |
|
|
2021
Q2 | $13.7M | Sell |
82,996
-2,336
| -3% | -$387K | 1.31% | 9 |
|
|
2021
Q1 | $14M | Buy |
85,332
+64,035
| +301% | +$10.4M | 1.41% | 12 |
|
|
2020
Q4 | $3.32M | Buy |
21,297
+1,707
| +9% | +$252K | 0.76% | 32 |
|
|
2020
Q3 | $2.92M | Buy |
19,590
+2,968
| +18% | +$439K | 0.54% | 43 |
|
|
2020
Q2 | $2.34M | Buy |
16,622
+1,035
| +7% | +$151K | 0.44% | 57 |
|
|
2020
Q1 | $2.04M | Sell |
15,587
-28,049
| -64% | -$3.98M | 0.49% | 62 |
|
|
2019
Q4 | $6.34M | Sell |
43,636
-135,899
| -76% | -$18.4M | 0.68% | 34 |
|
|
2019
Q3 | $23M | Buy |
179,535
+56,013
| +45% | +$7.38M | 1.18% | 10 |
|
|
2019
Q2 | $17.4M | Buy |
123,522
+8,108
| +7% | +$1.12M | 1.36% | 9 |
|
|
2019
Q1 | $16M | Buy |
115,414
+102,992
| +829% | +$13.8M | 1.32% | 10 |
|
|
2018
Q4 | $1.59M | Sell |
12,422
-146,656
| -92% | -$20.5M | 0.2% | 135 |
|
|
2018
Q3 | $21.9M | Sell |
159,078
-35,087
| -18% | -$4.66M | 1.29% | 5 |
|
|
2018
Q2 | $23.9M | Sell |
194,165
-158,684
| -45% | -$19.8M | 1.48% | 5 |
|
|
2018
Q1 | $44.8M | Buy |
352,849
+41,588
| +13% | +$5.62M | 1.83% | 4 |
|
|
2017
Q4 | $44M | Sell |
311,261
-20,073
| -6% | -$2.8M | 1.7% | 3 |
|
|
2017
Q3 | $43M | Sell |
331,334
-100,068
| -23% | -$13.3M | 1.76% | 4 |
|
|
2017
Q2 | $57.1M | Buy |
431,402
+178,417
| +71% | +$22.8M | 2.53% | 3 |
|
|
2017
Q1 | $31.4M | Sell |
252,985
-57,440
| -19% | -$6.86M | 1.24% | 9 |
|
|
2016
Q4 | $36M | Sell |
310,425
-166,701
| -35% | -$19.3M | 1.68% | 7 |
|
|
2016
Q3 | $56M | Buy |
+477,126
| New | +$57.9M | 2.76% | 2 |
|
|
2016
Q2 | – | Sell |
-425,274
| Closed | -$46.1M | – | 203 |
|
|
2016
Q1 | $46.1M | Sell |
425,274
-13,982
| -3% | -$1.45M | 2.38% | 2 |
|
|
2015
Q4 | $45.8M | Buy |
439,256
+136,593
| +45% | +$13.7M | 2.29% | 3 |
|
|
2015
Q3 | $28.2M | Sell |
302,663
-261,271
| -46% | -$25.3M | 1.51% | 8 |
|
|
2015
Q2 | $55M | Buy |
563,934
+137,386
| +32% | +$13.8M | 2.83% | 3 |
|
|
2015
Q1 | $43M | Hold |
426,548
| – | – | 2.06% | 5 |
|
|
2014
Q4 | $44.9M | Sell |
426,548
-23,514
| -5% | -$2.48M | 2.03% | 3 |
|
|
2014
Q3 | $48M | Sell |
450,062
-54,828
| -11% | -$5.69M | 2.22% | 4 |
|
|
2014
Q2 | $52.9M | Buy |
504,890
+152,044
| +43% | +$15.4M | 2.31% | 2 |
|
|
2014
Q1 | $34.6M | Sell |
352,846
-12,196
| -3% | -$1.13M | 2.56% | 3 |
|
|
2013
Q4 | $33.5M | Buy |
365,042
+6,855
| +2% | +$632K | 1.97% | 3 |
|
|
2013
Q3 | $31M | Buy |
358,187
+162,594
| +83% | +$14.6M | 2.18% | 2 |
|
|
2013
Q2 | $16.9M | Buy |
+195,593
| New | +$16.6M | 1.27% | 22 |
|
Other funds holding JNJ
Meag Munich Ergo's JNJ Position: Q2 2025 in Review
Meag Munich Ergo reduced its Johnson & Johnson (JNJ) stake by 5.1% in Q2 2025, selling an estimated $409K and leaving 49,967 shares worth $7.63M. The position accounts for 0.22% of the portfolio, ranked #78.
Meag Munich Ergo first reported a position in JNJ in Q2 2013 and has held it in 48 quarters since. The position peaked at $57.1M in Q2 2017. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.
- Meag Munich Ergo held 49,967 shares of Johnson & Johnson worth $7.63M as of Q2 2025.
- Meag Munich Ergo sold 2,662 Johnson & Johnson shares in Q2 2025, an estimated $409K.
- Johnson & Johnson made up 0.22% of Meag Munich Ergo's portfolio in Q2 2025, its #78 holding.
- Meag Munich Ergo first reported a position in Johnson & Johnson in Q2 2013 and has held it in 48 quarters since.
- Meag Munich Ergo's Johnson & Johnson position peaked at $57.1M in Q2 2017.
- 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.
Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.